*** For details on how to be removed from this list visit the *** *** CCP4 home page http://www.ccp4.ac.uk ***
Hi David, you do not give any info about your post-AMORE refinement protocol for crystal form 1. Could you please elaborate a little bit on that? In any case, I would recommend giving CNS and its simmulated annealing protocol a chance (with NCS restraints), at least in the first couple of rounds of your refinements, to help eliminate grossly incorrect main-chain/side-chain conformations 'trapped' at the interfaces of your tetramer and/or elsewhere. The way you carried out your MR (e.g. a monomer vs dimer vs tetramer as search models) could also be a factor. We had a case recently with three dimers in the asu (also in C2) in which searching with a monomer in PHASER using data to 2.5 angs (i.e. higher res. than the 15-4 angs one uses in AMORE) resulted in a better behaving model during early refinement rounds than searching with a dimer. In that case SA protocols in CNS were also important to help us get out of an early rut. Once the model was fairly robust we switched to REFMAC. Trying to reproduce the molecular replacement solution with other programs (e.g PHASER, MOLREP) may not be a bad idea afterall, as this could help you better evaluate the solution you already have. I hope this helps a little bit. Best wishes Savvas _________________________________________ Savvas N. Savvides Ghent University Laboratory for Protein Biochemistry K.L.Ledeganckstraat 35 9000 Ghent, BELGIUM Phone: +32-(0)9-264.51.24 ; +32-(0)472-92.85.19 FAX: +32-(0)9-264.53.38 Email: [EMAIL PROTECTED] ________________________________________ -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of david lawson (JIC) Sent: dinsdag 20 december 2005 12:53 To: ccp4bb Subject: [ccp4bb]: Molecular replacement in the "twilight zone" and space group problems *** For details on how to be removed from this list visit the *** *** CCP4 home page http://www.ccp4.ac.uk *** Dear All, We are having a lot of trouble with a particularly awkward protein and would be extremely grateful for any helpful suggestions. The protein appears to be a tetramer of 30 kDa subunits, as judged by dynamic light scattering and gel filtration, and so far we have obtained two crystal forms. Crystal form 1 - processes nicely as C2 with the following cell parameters: a = 86.5, b = 139.2, c = 100.7 Ang, beta = 101.6 deg. We have collected complete data to 2.1 Ang resolution. We estimate a solvent content of 50% for one tetramer per ASU. Crystal form 2 - processes equally well as rhombohedral, I centred tetragonal or F centred cubic (at the end of this message I have given a typical autoindexing run from Denzo). The crystals diffract strongly to at least 2 Ang resolution, but data collection much beyond 2.5 Ang in-house is difficult because of the long cell parameters. If the data are processed as F432, for example, this gives a solvent content of 65% for one tetramer per ASU. So far we have a molecular replacement solution for xtal form 1 that I think is essentially correct, as it gives sensible packing and a NCS 4-fold that is consistent with a peak in a self-rot function. However, the calculated phases are very poor because the template structure represents only about 65% of the target structure and the sequence identity is in the low 20s (the template was produced using CHAINSAW). Refinement on the structure beyond fitting in AMORE seems to make things worse. Running DM with 4-fold averaging seems to help, but the maps are heavily biased. I have taken advice from Kevin on which recipes to use, but so far have seen little improvement. My feeling is that if we could somehow refine the AMORE solution without it falling apart, perhaps we could get a better set of input phases for DM - any ideas here? Molecular replacement with data from xtal form 2 in a variety of space groups, doesn't yield any sensible solutions. We have some "derivative" data at 2.2 Ang resolution from crystals grown using tungstate as the precipitant. These were collected at the W L1 edge and appear to show a very significant anomalous signal. Eleanor took a look at these data (processed as F432) and found a native Patterson peak at 1/4,1/4,1/4, suggesting 2 molecules per ASU (this would give a solvent content of 30%). She also found 2 heavy atom sites with SHELX at 1/2,0,0 and the related 3/4,1/4,1/4, but these are not much use for anomalous phasing. Perhaps the anomalous signal is due to a lot of low occupancy binding sites. BTW, the data seem to pass all the tests in TRUNCATE for not being twinned. Any advice here would be appreciated. Clearly, working with xtal form 1 is the most straightforward, but if we can get some phase info for xtal form 2, then cross-xtal averaging becomes a possibility. Unfortunately, now we can only get crystals of form 2. Also the structure is unlikely to have any ordered Mets, so we have introduced 3 - now we can't get soluble Se-Met protein - but that's another story! Any helpful suggestions gratefully received. Many thanks, Dave Lawson Denzo autoindexing for xtal form 2: Lattice Metric tensor Best cell (symmetrized) distortion index Best cell (without symmetry restrains) primitive cubic 20.32% 154.43 154.65 154.40 60.16 60.00 60.21 154.49 154.49 154.49 90.00 90.00 90.00 I centred cubic 9.48% 218.47 154.40 155.03 90.10 90.19 89.94 175.96 175.96 175.96 90.00 90.00 90.00 F centred cubic 0.14% 218.60 218.47 218.99 89.83 89.77 89.91 218.69 218.69 218.69 90.00 90.00 90.00 primitive rhombohedral 0.07% 154.90 154.65 155.03 59.82 59.76 59.84 154.86 154.86 154.86 59.81 59.81 59.81 154.40 154.40 379.88 90.00 90.00 120.00 primitive hexagonal 16.53% 154.40 154.41 154.65 89.96 119.84 119.99 154.40 154.40 154.65 90.00 90.00 120.00 primitive tetragonal 20.32% 154.43 154.40 154.65 60.16 119.79 120.00 154.41 154.41 154.65 90.00 90.00 90.00 I centred tetragonal 0.13% 154.65 154.41 218.99 89.96 90.29 90.04 154.53 154.53 218.99 90.00 90.00 90.00 primitive orthorhombic 20.32% 154.40 154.43 154.65 119.79 119.84 60.00 154.40 154.43 154.65 90.00 90.00 90.00 C centred orthorhombic 16.53% 154.40 267.47 154.65 106.65 119.84 89.99 154.40 267.47 154.65 90.00 90.00 90.00 I centred orthorhombic 0.09% 154.40 155.03 218.47 89.81 89.94 89.90 154.40 155.03 218.47 90.00 90.00 90.00 F centred orthorhombic 0.13% 218.47 218.60 218.99 89.77 90.17 90.09 218.47 218.60 218.99 90.00 90.00 90.00 primitive monoclinic 16.53% 154.40 154.65 154.41 90.04 119.99 60.16 154.40 154.65 154.41 90.00 119.99 90.00 C centred monoclinic 0.02% 267.46 154.41 154.65 89.96 125.04 89.99 267.46 154.41 154.65 90.00 125.04 90.00 primitive triclinic 0.00% 154.40 154.41 154.65 89.96 60.16 60.01 autoindex unit cell 154.40 154.41 154.65 89.96 60.16 60.01 crystal rotx, roty, rotz -69.764 -31.667 -90.946 Autoindex Xbeam, Ybeam 150.14 150.50 ------------------------------- Dr. David M. Lawson Biological Chemistry Dept., John Innes Centre, Norwich, NR4 7UH, UK. Tel: +44-(0)1603-450725 Fax: +44-(0)1603-450018 Email: [EMAIL PROTECTED] Web: http://www.jic.bbsrc.ac.uk/staff/david-lawson/index.htm
